329 related articles for article (PubMed ID: 22461449)
21. Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis.
Ghallab A; González D; Strängberg E; Hofmann U; Myllys M; Hassan R; Hobloss Z; Brackhagen L; Begher-Tibbe B; Duda JC; Drenda C; Kappenberg F; Reinders J; Friebel A; Vucur M; Turajski M; Seddek AL; Abbas T; Abdelmageed N; Morad SAF; Morad W; Hamdy A; Albrecht W; Kittana N; Assali M; Vartak N; van Thriel C; Sous A; Nell P; Villar-Fernandez M; Cadenas C; Genc E; Marchan R; Luedde T; Åkerblad P; Mattsson J; Marschall HU; Hoehme S; Stirnimann G; Schwab M; Boor P; Amann K; Schmitz J; Bräsen JH; Rahnenführer J; Edlund K; Karpen SJ; Simbrunner B; Reiberger T; Mandorfer M; Trauner M; Dawson PA; Lindström E; Hengstler JG
J Hepatol; 2024 Feb; 80(2):268-281. PubMed ID: 37939855
[TBL] [Abstract][Full Text] [Related]
22. Nuclear factor-E2-related factor 2 expression in liver is critical for induction of NAD(P)H:quinone oxidoreductase 1 during cholestasis.
Aleksunes LM; Slitt AL; Maher JM; Dieter MZ; Knight TR; Goedken M; Cherrington NJ; Chan JY; Klaassen CD; Manautou JE
Cell Stress Chaperones; 2006; 11(4):356-63. PubMed ID: 17278884
[TBL] [Abstract][Full Text] [Related]
23. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
[TBL] [Abstract][Full Text] [Related]
24. Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine.
Weerachayaphorn J; Mennone A; Soroka CJ; Harry K; Hagey LR; Kensler TW; Boyer JL
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G925-36. PubMed ID: 22345550
[TBL] [Abstract][Full Text] [Related]
25. Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2-null mice.
Csanaky IL; Lu H; Zhang Y; Ogura K; Choudhuri S; Klaassen CD
Hepatology; 2011 Jan; 53(1):272-81. PubMed ID: 20949553
[TBL] [Abstract][Full Text] [Related]
26. ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling.
Tanaka Y; Aleksunes LM; Cui YJ; Klaassen CD
Toxicol Sci; 2009 Apr; 108(2):247-57. PubMed ID: 19181614
[TBL] [Abstract][Full Text] [Related]
27. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
[TBL] [Abstract][Full Text] [Related]
28. Atorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice.
Fu ZD; Cui JY; Klaassen CD
J Lipid Res; 2014 Dec; 55(12):2576-86. PubMed ID: 25278499
[TBL] [Abstract][Full Text] [Related]
29. Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor.
Zhang L; Shi J; Shen Q; Fu Y; Qi S; Wu J; Chen J; Zhang H; Mu Y; Chen G; Liu P; Liu W
J Ethnopharmacol; 2024 Jan; 318(Pt A):116833. PubMed ID: 37400008
[TBL] [Abstract][Full Text] [Related]
30. Modulation of transport and metabolism of bile acids and bilirubin by chlorogenic acid against hepatotoxicity and cholestasis in bile duct ligation rats: involvement of SIRT1-mediated deacetylation of FXR and PGC-1α.
Zhu L; Wang L; Cao F; Liu P; Bao H; Yan Y; Dong X; Wang D; Wang Z; Gong P
J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):195-205. PubMed ID: 29360226
[TBL] [Abstract][Full Text] [Related]
31. Solute Carrier Organic Anion Transporter Family Member 3A1 Is a Bile Acid Efflux Transporter in Cholestasis.
Pan Q; Zhang X; Zhang L; Cheng Y; Zhao N; Li F; Zhou X; Chen S; Li J; Xu S; Huang D; Chen Y; Li L; Wang H; Chen W; Cai SY; Boyer JL; Chai J
Gastroenterology; 2018 Nov; 155(5):1578-1592.e16. PubMed ID: 30063921
[TBL] [Abstract][Full Text] [Related]
32. Osteopontin is an initial mediator of inflammation and liver injury during obstructive cholestasis after bile duct ligation in mice.
Yang M; Ramachandran A; Yan HM; Woolbright BL; Copple BL; Fickert P; Trauner M; Jaeschke H
Toxicol Lett; 2014 Jan; 224(2):186-95. PubMed ID: 24188933
[TBL] [Abstract][Full Text] [Related]
33. Organic Anion Transporting Polypeptide (OATP) 1B3 is a Significant Transporter for Hepatic Uptake of Conjugated Bile Acids in Humans.
Pan Q; Zhu G; Xu Z; Zhu J; Ouyang J; Tong Y; Zhao N; Zhang X; Cheng Y; Zhang L; Tan Y; Li J; Zhang C; Chen W; Cai SY; Boyer JL; Chai J
Cell Mol Gastroenterol Hepatol; 2023; 16(2):223-242. PubMed ID: 37146714
[TBL] [Abstract][Full Text] [Related]
34. Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury.
Iruzubieta P; Goikoetxea-Usandizaga N; Barbier-Torres L; Serrano-Maciá M; Fernández-Ramos D; Fernández-Tussy P; Gutiérrez-de-Juan V; Lachiondo-Ortega S; Simon J; Bravo M; Lopitz-Otsoa F; Robles M; Ferre-Aracil C; Varela-Rey M; Elguezabal N; Calleja JL; Lu SC; Milkiewicz M; Milkiewicz P; Anguita J; Monte MJ; Marin JJG; López-Hoyos M; Delgado TC; Rincón M; Crespo J; Martínez-Chantar ML
JHEP Rep; 2021 Jun; 3(3):100276. PubMed ID: 33997750
[TBL] [Abstract][Full Text] [Related]
35. Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns.
Juanola O; Hassan M; Kumar P; Yilmaz B; Keller I; Simillion C; Engelmann C; Tacke F; Dufour JF; De Gottardi A; Moghadamrad S
Gut Microbes; 2021; 13(1):1-20. PubMed ID: 33847205
[TBL] [Abstract][Full Text] [Related]
36. PGC1α deficiency reverses cholestasis-induced liver injury via attenuating hepatic inflammation and promoting bile duct remodeling.
Li D; Ye C; Liu P; Sun T; Qin Y; Wan X
Acta Histochem; 2023 Dec; 125(8):152097. PubMed ID: 37813066
[TBL] [Abstract][Full Text] [Related]
37. Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury.
Sommer J; Dorn C; Gäbele E; Bataille F; Freese K; Seitz T; Thasler WE; Büttner R; Weiskirchen R; Bosserhoff A; Hellerbrand C
Cells; 2020 Jan; 9(1):. PubMed ID: 31963815
[TBL] [Abstract][Full Text] [Related]
38. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
[TBL] [Abstract][Full Text] [Related]
39. Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis.
Park YJ; Qatanani M; Chua SS; LaRey JL; Johnson SA; Watanabe M; Moore DD; Lee YK
Hepatology; 2008 May; 47(5):1578-86. PubMed ID: 18393320
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of hepatic organic cation transporter 1, organic anion-transporting polypeptide 1a4, bile-salt export pump, and multidrug resistance-associated protein 2 transporter expression in lymphocyte-deficient mice associates with interleukin-6 production.
Bodeman CE; Dzierlenga AL; Tally CM; Mulligan RM; Lake AD; Cherrington NJ; McKarns SC
J Pharmacol Exp Ther; 2013 Oct; 347(1):136-44. PubMed ID: 23929842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
